GSPT1 / ERF3A antibody

Principal name

GSPT1 / ERF3A antibody

Alternative names for GSPT1 / ERF3A antibody

Eukaryotic peptide chain release factor GTP-binding subunit ERF3A, Eukaryotic peptide chain release factor subunit 3a, G1 to S phase transition protein 1 homolog

SwissProt ID

P15170 (Human), Q8R050 (Mouse)

Gene ID

2935 (GSPT1)

Available reactivities

Hu (Human), Ms (Mouse), Rt (Rat), Bov (Bovine), Can (Canine), Por (Porcine), Rb (Rabbit)

Available hosts

Mouse, Rabbit

Available applications

Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P)

Background of GSPT1 / ERF3A antibody

Kit Component:
- KN200467G1, GSPT1 gRNA vector 1 in pCas-Guide vector
- KN200467G2, GSPT1 gRNA vector 2 in pCas-Guide vector
- KN200467D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector
CRISPR Manual:
CRISPR/CAS9 Genome Editing Manual

14 Item(s)

per page

Primary Antibodies

Catalog No. Host Iso. Clone Pres. React. Applications  

GSPT1 / ERF3A antibody

WB Suggested Anti-GSPT1 Antibody; Titration: 1.0 ug/ml; Positive Control: HepG2 Whole Cell GSPT1 is strongly supported by BioGPS gene expression data to be expressed in Human HepG2 cells Rabbit IgG Purified Bov, Can, Hu, Por, Rb, Rt WB
50 µg / €325.00
  OriGene Technologies, Inc.

GSPT1 / ERF3A antibody

GSPT1 / ERF3A Mouse Serum Hu E, WB
50 µl / €290.00
  Abnova Taiwan Corp.

GSPT1 / ERF3A antibody

Immunohistochemistry analysis of paraffin-embedded human prostate carcinoma tissue, using GSPT1 Antibody. The picture on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, P
50 µg / €205.00
  Assay Biotech

GSPT1 / ERF3A antibody

Immunohistochemistry analysis of paraffin-embedded human prostate carcinoma tissue, using GSPT1 Antibody. The picture on the right is treated with the synthesized peptide. Rabbit Aff - Purified Hu, Ms, Rt E, P
0.1 mg / €310.00
  Assay Biotech

Proteins & Growth Factors

Catalog No. Species Pres. Purity Source  

GSPT1 / ERF3A

GSPT1 / ERF3A Human Purified
10 µg / €380.00
  Abnova Taiwan Corp.

GSPT1 / ERF3A

GSPT1 / ERF3A Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
10 µg / €380.00
  Abnova Taiwan Corp.

GSPT1 / ERF3A

GSPT1 / ERF3A Human Purified 12.5% SDS-PAGE Stained with Coomassie Blue.
25 µg / €510.00
  Abnova Taiwan Corp.

GSPT1 / ERF3A

GSPT1 / ERF3A Human 12.5% SDS-PAGE Stained with Coomassie Blue. in vitro transl.
10 µg / €380.00
  Abnova Taiwan Corp.

GSPT1 / ERF3A

GSPT1 / ERF3A Human 12.5% SDS-PAGE Stained with Coomassie Blue. in vitro transl.
25 µg / €510.00
  Abnova Taiwan Corp.

Lysates

Catalog No.    

GSPT1 overexpression lysate

GSPT1 overexpression lysate  
0.1 mg / €280.00
  OriGene Technologies, Inc.

Human Lenti ORF Particles

Catalog No.    

Lenti ORF particles, GSPT1 (mGFP-tagged) - Human G1 to S phase transition 1 (GSPT1), transcript variant 2, 200 uL, >10^7 TU/mL

Lenti ORF particles, GSPT1 (mGFP-tagged) - Human G1 to S phase transition 1 (GSPT1), transcript variant 2, 200 uL, >10^7 TU/mL  
200 µl / €1,300.00
  OriGene Technologies, Inc.

Lenti ORF particles, GSPT1 (mGFP-tagged)-Human G1 to S phase transition 1 (GSPT1), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, GSPT1 (mGFP-tagged)-Human G1 to S phase transition 1 (GSPT1), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €1,050.00
  OriGene Technologies, Inc.

Lenti ORF particles, GSPT1 (Myc-DDK tagged) - Human G1 to S phase transition 1 (GSPT1), transcript variant 2 , 200 uL, >10^7 TU/mL

Lenti ORF particles, GSPT1 (Myc-DDK tagged) - Human G1 to S phase transition 1 (GSPT1), transcript variant 2 , 200 uL, >10^7 TU/mL  
200 µl / €1,170.00
  OriGene Technologies, Inc.

Lenti ORF particles, GSPT1 (Myc-DDK-tagged)-Human G1 to S phase transition 1 (GSPT1), transcript variant 3, 200 uL, >10^7 TU/mL

Lenti ORF particles, GSPT1 (Myc-DDK-tagged)-Human G1 to S phase transition 1 (GSPT1), transcript variant 3, 200 uL, >10^7 TU/mL  
200 µl / €940.00
  OriGene Technologies, Inc.

14 Item(s)

per page
  • LinkedIn